The Business of Stem Cells and Regenerative Medicine. Caltech/MIT Enterprise Forum. Technologies for creating, modifying and using stem cells in the treatment of human diseases and disorders show great promise, but involve inexpensive high-risk development as well as high levels of political, legal and ethical sensitivity. Given this landscape, how does one start and fund a new venture involving stem cells or other aspects of regenerative medicine? The November 12 program will focus on these business opportunities and challenges and potential strategies for surmounting them. See http://www.entforum.caltech.edu |